News
Bengaluru: AstraZeneca is reportedly in discussions with Summit Therapeutics to license an experimental lung cancer drug in a ...
Modella AI has signed a multi-year agreement with AstraZeneca for expediting AI-driven oncology clinical development.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback